Your browser doesn't support javascript.
loading
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial.
Korsatko, Stefan; Jensen, Lene; Brunner, Martina; Sach-Friedl, Stefanie; Tarp, Maja D; Holst, Anders G; Heller, Simon R; Pieber, Thomas R.
Afiliación
  • Korsatko S; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Jensen L; Novo Nordisk A/S, Søborg, Denmark.
  • Brunner M; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Sach-Friedl S; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Tarp MD; Novo Nordisk A/S, Aalborg, Denmark.
  • Holst AG; Novo Nordisk A/S, Søborg, Denmark.
  • Heller SR; University of Sheffield Medical School, Sheffield, UK.
  • Pieber TR; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Diabetes Obes Metab ; 20(11): 2565-2573, 2018 11.
Article en En | MEDLINE | ID: mdl-29893488

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón / Hipoglucemia Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón / Hipoglucemia Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Austria